Centessa Pharmaceuticals plc (CNTA)
NASDAQ: CNTA · Real-Time Price · USD
39.61
+0.02 (0.05%)
At close: Apr 15, 2026, 4:00 PM EDT
39.05
-0.56 (-1.41%)
After-hours: Apr 15, 2026, 4:40 PM EDT
Centessa Pharmaceuticals Revenue
In the year 2025, Centessa Pharmaceuticals had annual revenue of $15.00M.
Revenue (ttm)
$15.00M
Revenue Growth
n/a
P/S Ratio
408.41
Revenue / Employee
$127,119
Employees
118
Market Cap
6.13B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 15.00M | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 6.85M | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PTC Therapeutics | 1.73B |
| Mirum Pharmaceuticals | 521.31M |
| Rhythm Pharmaceuticals | 189.76M |
| Protagonist Therapeutics | 46.02M |
| Xenon Pharmaceuticals | 7.50M |
| CG Oncology | 4.04M |
CNTA News
- 15 days ago - Nxera Pharma's Partner Centessa Pharmaceuticals to be Acquired by Lilly - GlobeNewsWire
- 15 days ago - Eli Lilly stock rises after $7.8B Centessa deal—bet on sleep drugs - Invezz
- 15 days ago - Lilly to spend up to $7.8 billion to acquire Centessa, a maker of experimental sleep disorder drugs - CNBC
- 15 days ago - Eli Lilly to Buy Centessa Pharmaceuticals for Initial $6.3 Billion - WSJ
- 15 days ago - Eli Lilly to buy Centessa Pharma in $6.3 billion deal - Reuters
- 15 days ago - Lilly to acquire Centessa Pharmaceuticals to advance treatments for sleep-wake disorders - PRNewsWire
- 5 weeks ago - Nxera Pharma to Receive US$3 Million Milestone Payment from Centessa Pharmaceuticals - GlobeNewsWire
- 2 months ago - Nxera Pharma to Receive $1.8 Million Milestone Payment from Centessa Pharmaceuticals - GlobeNewsWire